Home > Drug Search >
  • company_query: Beijing Bo Li Weikang
  •   > 
Drug Filter
Category:
chemistry (28) biology (25)
Status:
Approved (7) NDA Filing (1) Phase Ⅲ (11) Phase Ⅱ (12) Phase Ⅰ (22)
Clinical Stage:
Pending (6) Active (34) Discontinued (6)
Bio-Type:
Gene therapy (1) Vaccine (4) Blood extraction (1) Recombinant enzyme (1) Recombinant coagulation factor (1) Recombinant cytokines (1) Whole antibody (8)
Indication:
Acute myeloid Leukemia (AML) (1) Anemia (1) Atopic dermatitis (1) Atrial fibrillation (2) Breast cancer (2) Chronic lymphocytic leukemia (CLL) (1) Guillain-Barre syndrome (1) Mucocutaneous lymph node syndrome (Kawasaki syndrome) (1) Agammaglobulinaemia (1) Chronic obstructive pulmonary disease (COPD) (1) Avian influenza (1) Depression (1) Epilepsy/Seizures (1) Gastric cancer (1) HBV infection (2) HIV infection (1) Inflammatory bowel disease (1) Influenza virus infection (3) Lung cancer (1) Lymphoma (1) Melanoma (4) Multiple myeloma (MM) (1) Neuropathic pain (1) Non small cell lung cancer (NSCLC) (3) Non-Hodgkin B-cell lymphomas (1) Osteoarthritis (OA) (1) Ovarian cancer (1) Pancreatic cancer (3) Parkinson's disease (PD) (1) Postoperative pain (1) Primary hypertension (1) Diphtheria (2) Pertussis (1) Tetanus (2) Psoriasis (1) Psoriatic arthritis (1) Pulmonary arterial hypertension (1) Rheumatoid arthritis (RA) (2) Varicella zoster virus infections (1) Schizophrenia (1) Soft tissue sarcoma (1) Solid tumours (3) Type 2 diabetes (1) Ulcerative colitis (1) Uveitis (1) Fabry disease (1) Colorectal cancer (3) Colon cancer (1) Anthrax (1) Neuroblastoma (1) Stroke (1) Metastatic non-small cell lung cancer (1) Waldenström's macroglobulinemia (WM) (1) B-cell lymphoma (1) HER2-positive metastatic breast cancer (2) Hemophilia A (1) Neutropenia (1) Acute myocardial infarction (AMI) (1) Hypoactive sexual desire disorder (HSDD) (1) Spinocerebellar ataxia (1) Oculopharyngeal muscular dystrophy (1) Fatty aldehyde dehydrogenase deficiency (1) Opioid dependency (1) Glioma (2) Esophagus cancer (1) Mesothelioma (1) Diffuse large B cell lymphoma (1) Stem cell mobilization (1) Immunodeficiency disorders (1) Thromboembolism (1) Infectious disease (1) Inflammatory pain (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top